🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David Wallon

Inserm

ORCID: 0000-0002-2634-7198

Also affiliated with Normandie Université, Université de Rouen Normandie

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.9Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Nature Communications(2021)10.1038/s41467-021-22491-8
Top 6%
3.9DataRank
Top 6%339 citations

Sonia Moreno–Grau, Niccoló Tesi, Benjamin Grenier‐Boley, Víctor Andrade, Iris E. Jansen +95 more

Papers

Driven by 12 papers — median percentile 0. Top paper: “Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores”.

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Nature Communications(2021)10.1038/s41467-021-22491-8
Top 6%
3.9DataRank
Top 6%339 citations

Sonia Moreno–Grau, Niccoló Tesi, Benjamin Grenier‐Boley, Víctor Andrade, Iris E. Jansen +95 more

Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease

Annals of Neurology(2022)10.1002/ana.26511
N/A
1.8DataRank · unranked
44 citations

Jorge J. Llibre‐Guerra, Yan Li, Austin McCullough, Carsten Hofmann, Jakub Wojtowicz +49 more

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

The Lancet Neurology(2025)10.1016/s1474-4422(25)00024-9
N/A
1.2DataRank · unranked
41 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +62 more

Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

European Journal of Nuclear Medicine and Molecular Imaging(2023)10.1007/s00259-023-06209-0
N/A
0.765DataRank · unranked
24 citations

Austin McCullough, Brian A. Gordon, Nelly Joseph‐Mathurin, Shaney Flores, Nicole S. McKay +48 more

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial

medRxiv(2024)10.1101/2024.10.29.24316289
N/A
0.351DataRank · unranked
6 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +63 more

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

WOS(2020)10.17863/cam.70957
Top 100%
0DataRank
Top 100%0 citations

Sonia Moreno–Grau, Niccoló Tesi, Benjamin Grenier‐Boley, Víctor Andrade, Iris E. Jansen +95 more

“Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene-dose-sensitive AD-suppressor in human brain”

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.29.918037
N/A
0DataRank · unranked
26 citations

Pollyanna Goh, Aoife Murray, Erik Portelius, Eleni Gkanatsiou, Gillian Gough +37 more

Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Nature Communications(2023)10.1038/s41467-023-36192-x
Top 100%
0DataRank
Top 100%0 citations

Sonia Moreno–Grau, Niccoló Tesi, Benjamin Grenier‐Boley, Víctor Andrade, Iris E. Jansen +95 more

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials

The Journal of Prevention of Alzheimer s Disease(2024)10.14283/jpad.2024.61
N/A
0DataRank · unranked
4 citations

Jonathan Li, Ellen Ziegemeier, Sarah F. Adams, Eric McDade, David B. Clifford +34 more

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

UNC Libraries(2020)10.17615/pbds-w495
N/A
0DataRank · unranked
0 citations

David Craig, Liming Qu, Jonathan L. Haines, Taniesha Morgan, Mark A. Sager +95 more

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Molecular Psychiatry(2020)10.1038/s41380-020-0806-5
N/A
0DataRank · unranked
123 citations

Pollyanna Goh, Aoife Murray, Erik Portelius, Eleni Gkanatsiou, Gillian Gough +41 more

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Nature Medicine(2021)10.1038/s41591-021-01369-8
N/A
0DataRank · unranked
365 citations

Martin R. Farlow, Eric McDade, David B. Clifford, Guoqiao Wang, Jorge J. Llibre‐Guerra +61 more